Clovis Oncology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CLVSQ and buy or sell other stocks, ETFs, and their options commission-free!About CLVSQ
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy.
CEOPatrick J. Mahaffy
CEOPatrick J. Mahaffy
Employees—
Employees—
HeadquartersBoulder, Colorado
HeadquartersBoulder, Colorado
Founded2009
Founded2009
Employees—
Employees—
CLVSQ Key Statistics
Market cap2.17M
Market cap2.17M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume1.16M
Average volume1.16M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.87
52 Week high$2.87
52 Week low$0.0102
52 Week low$0.0102
People also own
Based on the portfolios of people who own CLVSQ. This list is generated using Robinhood data, and it’s not a recommendation.